Xenon Inhalation for Treatment of Panic Disorder

A Double-Blind, Randomized, Placebo-Controlled Trial of Xenon Inhalation for Treatment of Patients With Panic Disorder

This study is a double-blind, randomized, placebo-controlled, clinical trial in parallel groups in patients with panic disorder.

Inclusion Criteria:

• Primary diagnosis of panic disorder according to DSM-5.
• Male and female patients ≥18 years of age.

Exclusion Criteria:

• History of schizophrenia, bipolar and other psychotic disorders.
• Patients with underlying pulmonary disease, chronic obstructive pulmonary disease (COPD), asthma, severe lung disease and/or baseline oxygen saturations <92% or any other respiratory conditions / diseases that may affect the respiratory function.
• Currently undergoing targeted empirically-driven psychotherapy for panic disorder or panic disorder-related symptoms.
• Currently undergoing exposure-based psychotherapy for any condition.